Understanding the Mechanisms Blocking Cancer Cell Growth
News Jan 29, 2016
A study lead by Antoine Simoneau of the laboratory of Dr. Hugo Wurtele, a researcher in immunology-oncology at the Maisonneuve-Rosemont Hospital (CIUSS de l'Est-de-l'Île-de-Montréal) and professor at the Faculty of Medicine, University of Montreal provides valuable information about certain mechanisms governing DNA repair. The study is a collaboration between several institutions and opens the way to better understand the mechanisms of action of drugs that prevent cancer cell growth.
To adapt to the small size of cell nuclei, DNA wraps around proteins called histones to form chromatin. Cells can chemically modify histones so as to change chromatin structure and thereby control the various functions of DNA. Recent research has shown that new drugs that inhibit histone deacetylases (HDACs), which affect chromatin, are promising for cancer treatment.
The study by Dr. Wurtele's research team and collaborators used yeast as a model system to understand, at a molecular level, the mechanisms that influence cell growth in the presence of a particular class of HDACs.
The experiments demonstrate that Class III HDACs, which influence various cellular processes involved in carcinogenesis and response to chemotherapy agents, strongly block cell proliferation by preventing the normal functioning of various factors involved in the response to DNA damage spontaneously generated by cellular metabolism.
"This basic research allows for a better understanding of the overall effects of HDAC inhibitors on cells and can eventually lead to an optimization of their clinical use," said Dr. Wurtele.
These findings will guide future research at Dr. Wurtele's laboratory to determine how this new class of drugs inhibits the growth of cancer cells.
Targeted Drug Could be Used to Treat Advanced Cancers Located Anywhere in the BodyNews
A new targeted drug could be used to treat a small number of advanced cancers no matter where they grow in the body.READ MORE
CRISPR Study Reveals Errors in Earlier Cancer ResearchNews
MELK, a protein previously thought to be implicated in cancer, has been shown to be unrelated to the disease.READ MORE